Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue

Hormone Research in Paediatrics

Volumn 47, Issue 2, 1997, Pages 54-61

  Kauli, R ^a   Galatzer, A ^a   Kornreich, L ^b   Lazar, L ^a   Pertzelan, A ^a   Laron, Z ^a  

^a Institute of Pediatric and Adolescent Endocrinology   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Bayley and Pinneau; Cyproterone acetate therapy; Final height; Final height prediction by; GnRH analogue therapy; Precocious puberty

Indexed keywords

CYPROTERONE ACETATE; GONADORELIN DERIVATIVE; TRIPTORELIN;

ARTICLE; BONE AGE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEIGHT; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRECOCIOUS PUBERTY; PREDICTION; PRIORITY JOURNAL; PUBERTY; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADOLESCENT; ANDROGEN ANTAGONISTS; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; CYPROTERONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; LUTEOLYTIC AGENTS; PUBERTY, PRECOCIOUS; TREATMENT OUTCOME; TRIPTORELIN;

EID: 0031012502     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000185432     Document Type: Article

References (38)

1. Thamdrup E: Precocious Sexual Development: A Clinical Study of 100 Children. Springfield. Thomas. 1961. pp 44-63.
2. Sigurjonsdottir TJ. Havles AB: Precocious puberty: A report of 96 cases. Am J Dis Child 1968;115:309-321.
3. Cloutier MD. Hales AB: Precocious puberty. Adv Pediatr 1970:17:126-138.
4. Murram D, Dcwhurst J, Grant DB: Precocious puberty: A follow-up study. Arch Dis Child 1984:59:77-78.
5. Crowley WF, Comite F, Vale W, Rivicr J, Loriaux DL, Cutler GB Jr.: Therapeutic use of pituitary desensitization with long-acting LHRH agonist: A potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 1981:52:370-372.
6. Laron Z, Kauli R, Ben Zccv Z, Comaru-Schally AM, Schally AV: D-TRP-6-analogue of luteinizing hormone-releasing hormone in combination with cyproterone acetate to treat precocious puberty. Lancet 1981:1:955-956.
7. Helgc H, Weber B, Hammcrstcin I, Neumann F: Idiopathic precocious puberty, indications for use of cyproterone acetate, an antigonado-trophic and antiandrogenic substance? Acta Paediatr Scand 1969:58:672.
8. Kauli R. Pcrtzclan A. Prager-Lewin R. Grunc-baum M. Laron Z: Cyproterone acetate in treatment of precocious puberty. Arch Dis Child 1976;51:202-208.
9. Boepple PA, Mansfield MJ, Crawford JD, Crigler JF Jr., Blizzard RM, Crowley WF Jr.: Gonadotropin-releasing hormone agonist treatment of central puberty: An analysis of growth data in a developmental context. Acta Paediatr Scand 1990:367(suppl):38-43.
10. Oostdijk W, Drop SL, Odink RJ, Hutnmelink R, Partsch CJ, Sippel WG: Long-term results with a slow-relcase GnRH agonist in central precocious puberty. Acta Paediatr Scand 1991: 372(suppl):39-45.
11. Swaenepoe C, Chaussain JL, Roger M: Longterm results of long-acting luteinizing-hor-mone-releasing hormone agonist in central precocious puberty. Horm Res 1991;36:126-130.
12. Brauncr R. Malandrv F. Rappaport R: Predictive factors for the effect of gonadotrophin releasing hormone analogue therapy on the height of girls with idiopathic precocious puberty. Eur J Pediatr 1992;151:728-730.
13. Hummelink R, Oostdijk W, Partsch CJ, Odink RJ, Drop SL, Sippel WG: Growth, bone maturation, and height prediction after three years of therapy with the slow release GnRH-agonist Dccapcptyl depot in children with central precocious puberty. Horm Metab Res 1992:24: 122-126.
14. Partsch CJ, Hummelink R, Peter M, Sippel WG, Oostdijk W, Odink RJ, Drop SL: Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. Horm Res 1993;39:111-117.
15. Jay N, Mansfield MJ, Blizzard RM, Crowley WF Jr., Schoenfeld D, Rhubin L, Boepple PA: Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab 1992:75: 890-894.
16. Kauli R. Komrcich L. Laron Z: Pubertal development. growth and final height in girls with sexual precocity after therapy with the GnRH analogue J-TRP-6-LHRH. Horm Res 1990: 33:11-17.
17. Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Cutler JB Jr.: Adult height in precocious puberty after long-term treatment with dcslore-lin. J Clin Endocrinol Metab 1991:73:1235-1240.
18. Boepple PA, Mansfield MJ, Crawford JD, Crigler JF Jr., Blizzard RM, Crowley WF Jr.: Final heights in girls with central precocious puberty following GnRH agonist-induced pituitary-gonadal suppression. Pediatr Res 1991; 29:74A.
19. Kauli R, Komrcich L, Laron Z: Final outcome in precocious puberty treated with GnRH analogue: in Lunenfeld B (ed): The Basic Science of GnRH Analogues. Advances in the Study of GnRH Analogues. Camforth. Parthenon Publishing. 1992. vol 2. pp 147-156.
20. Oerter KE, Manasco PK, Barnes KM, Jones J, Hill S, Cutler GB Jr.: Effect of luteinizing hormone-releasing hormone agonist on final height in luteinizing hormone-releasing hormone dependent precocious puberty. Acta Paediatr 1993;388(suppl):62-68.
21. Klctter GB. Kelch RP: Effect of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab 1994;79:331-334.
22. Brauncr R, Adan L, Malandry F, Zantlcifer D: Adult height in girls with idiopathic true precocious puberty. J Clin Endocrinol Metab 1994: 79:415-420.
23. Paul D, Conte FA, Grumbach MM, Kaplan SL: Long-term effect of gonadotropin-releasing hormone agonist therapy on final or near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metabol 1995:80:546-551.
24. Bayley N, Pinneau SR: Tables for predicting adult height from skeletal age revised for use with the Greulich-Pyle hand standards. J Pediatr 1952:40:432-441.
25. Zachmann M, Sobradillo B, Frank M, Frisch H, Prader A: Bayley-Pinneau. Roche-Wainer-Thissen and Tanner height predictions in normal children and in patients with various pathological conditions. J Pediatr 1978:93: 749-755.
26. Bar A. Linder B. Sobel EH. Saengcr P. DiMar-tino-Nardi J: Bayley-Pinneau method ofheight prediction in girls with central precocious puberty: Correlation with adult height. J Pediatr 1995:126:955-958.
27. Kirkland JL. Gibbs AR. Kirkland RT. Clayton GW: Height predictions in girls with idiopathic precocious puberty by the Bayley-Pinneau method. Pediatrics 1981:68:251-252.
28. Tanner JM, Goldstein H, Whitehouse RH: Standards for children's height at ages 2-9 years allowing for height of parents. Arch Dis Child 1970:45:755-762.
29. Greulich WW. Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist, ed 2. Standford. Standford University Press. 1959.
30. Fonloura M, Brauncr R, Prevot C, Rappaport R: Precocious puberty in girls: Early diagnosis of a slowly progressing variant. Arch Dis Child 1989:64: 1170-1176.
31. Krcitcr M, Burstein S, Roscnficld RL, Moll GW Jr., Cara JF, Yousefzadeh DK, Cuttlcr L, Levitsky LL: Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr 1990:117:364-370.
32. Tanner JM: Growth and Adolescence, ed 2. Oxford. Blackwell Scientific Publications, 1962. p 96.
33. Kauli R, Prager-Lewin R, Keret R, Laron Z: The LH and FSH responses to LH-rclcasing hormone in girls with true precocious puberty treated with cyproterone acetate. Eur J Pediatr 1977:125:205-212.
34. Girard J, Bauman JB, Buhler U, Zuppingcr K, Haas HG, Staub JJ, Wyss HI: Cyproterone acetate and ACTH adrenal function. J Clin Endocrinol Metab 1978;47:581-586.
35. Stivel MS, Kauli R, Kaufman H, Laron Z: Adrenocortical function in children with precocious sexual development during treatment with cyproterone acetate. Clin Endocrinol 1982:16:163-169.
36. Sorgo W, Kiraly E, Homoki J, Heinze E, Teller WM, Bierich JR, Moeller H, Ranke MB, Bu-tcnandt O, Knorr D: The effect of cyproterone acetate on statural growth in children with precocious puberty. Acta Endocrinol (Copenh) 1987;115:44-56.
37. Cistemino M, Pasquino AM, Bozzola M, Bal-ducci R, Lorini R, Pucarclli I: Final height attainment and gonadal function in girls with precocious puberty treated with cyproterone acetate. Horm Res 1992:37:86-90.
38. Kato K, Fujimoto M, Hibi I, Suwa S, Shimizu N: The long-term effect of cyproterone acetate on growth of girls with idiopathic precocious puberty. Eur J Pediatr 1993:152:297-300.